Spruce Biosciences Stock Price on December 4, 2024
| SPRB Stock | USD 0.43 0.11 20.37% |
Below is the normalized historical share price chart for Spruce Biosciences extending back to October 09, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Spruce Biosciences stands at 0.43, as last reported on the 12th of December 2024, with the highest price reaching 0.44 and the lowest price hitting 0.38 during the day.
If you're considering investing in Spruce Stock, it is important to understand the factors that can impact its price. Spruce Biosciences owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0104, which indicates the firm had a -0.0104% return per unit of risk over the last 3 months. Spruce Biosciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Spruce Biosciences' Variance of 18.08, risk adjusted performance of 0.0067, and Coefficient Of Variation of (46,065) to confirm the risk estimate we provide.
At present, Spruce Biosciences' Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 62.6 M, whereas Total Stockholder Equity is forecasted to decline to about 65.5 M. . At present, Spruce Biosciences' Price Book Value Ratio is projected to slightly grow based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.07, whereas Price To Sales Ratio is forecasted to decline to 8.94. Spruce Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of October 2020 | 200 Day MA 0.8612 | 50 Day MA 0.5128 | Beta 2.369 |
Spruce |
Sharpe Ratio = -0.0104
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SPRB |
Estimated Market Risk
| 4.33 actual daily | 38 62% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Spruce Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spruce Biosciences by adding Spruce Biosciences to a well-diversified portfolio.
Price Book 0.3435 | Enterprise Value Ebitda (0.23) | Price Sales 2.4982 | Shares Float 24.9 M | Wall Street Target Price 1.8333 |
Related Headline
Day One Headline on 4th of December 2024
Dawn Protocol Trading 1 percent Lower This Week by thelincolnianonline.com
Dawn Protocol traded down 0.3 percent against the U.S. dollar during the one day period ending at 1200 PM E.T. on December 4th. In the last seven days, Dawn Protocol has traded down 1 percent against the U.S. dollar. Dawn Protocol has a market capitalization of 78,435.24 and 22.20 worth of Dawn Protocol was traded on
Spruce Biosciences Valuation on December 4, 2024
It is possible to determine the worth of Spruce Biosciences on a given historical date. On December 4, 2024 Spruce was worth 0.55 at the beginning of the trading date compared to the closed value of 0.52. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Spruce Biosciences stock. Still, in general, we apply an absolute valuation method to find Spruce Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Spruce Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Spruce Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 0.55 | 0.57 | 0.50 | 0.54 | 466,215 | |
12/04/2024 | 0.55 | 0.55 | 0.52 | 0.52 | 227,926 |
| 0.53 | 0.53 | 0.49 | 0.50 | 245,754 |
| Backtest Spruce Biosciences | | | Spruce Biosciences History | | | Spruce Biosciences Valuation | Previous | Next |
Spruce Biosciences Trading Date Momentum on December 4, 2024
| On December 05 2024 Spruce Biosciences was traded for 0.50 at the closing time. The top price for the day was 0.53 and the lowest listed price was 0.49 . The trading volume for the day was 245.8 K. The trading history from December 5, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 3.85% . The trading price change against the current closing price is 19.23% . |
Spruce Biosciences Fundamentals Correlations and Trends
By evaluating Spruce Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Spruce Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Spruce financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Spruce Biosciences Stock history
Spruce Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Spruce is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Spruce Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Spruce Biosciences stock prices may prove useful in developing a viable investing in Spruce Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 38.5 M | 24.9 M | |
| Net Loss | -41.6 M | -43.6 M |
Spruce Biosciences Quarterly Net Working Capital |
|
Spruce Biosciences Stock Technical Analysis
Spruce Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Spruce Biosciences Period Price Range
Low | December 12, 2024
| High |
0.00 | 0.00 |
Spruce Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Spruce Biosciences December 12, 2024 Market Strength
Market strength indicators help investors to evaluate how Spruce Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Spruce Biosciences shares will generate the highest return on investment. By undertsting and applying Spruce Biosciences stock market strength indicators, traders can identify Spruce Biosciences entry and exit signals to maximize returns
Spruce Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Spruce Biosciences' price direction in advance. Along with the technical and fundamental analysis of Spruce Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Spruce to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0067 | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.69) | |||
| Treynor Ratio | (0.02) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Spruce Stock analysis
When running Spruce Biosciences' price analysis, check to measure Spruce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spruce Biosciences is operating at the current time. Most of Spruce Biosciences' value examination focuses on studying past and present price action to predict the probability of Spruce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spruce Biosciences' price. Additionally, you may evaluate how the addition of Spruce Biosciences to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |